Oramed Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Oramed Pharmaceuticals.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Oramed Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Sep 9, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 20, 2024
Edward Nash Canaccord Genuity	Canaccord Genuity	Hold Maintains $3 → $2	Hold	Maintains	$3 → $2	-5.66%	May 17, 2023
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jan 17, 2023
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jan 12, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.34M

Revenue Next Year

1.02M

EPS This Year

-0.04

from 0.14

EPS Next Year

-0.12

from -0.04

Fiscal Year	FY 2020	FY 2021	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Aug 31, 2021	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	2.71M	2.70M	2.71M	2.70M	1.34M	-	1.02M
Revenue Growth	0.07%	-0.33%	0.33%	-0.33%	-50.43%	-	-
EPS	-0.90	-0.78	-0.94	-0.94	0.14	-0.04	-0.12
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	n/a	2.1M
Avg	n/a	1.0M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2024	2025
High	0.18	-0.13
Avg	-0.04	-0.12
Low	-0.24	-0.12

EPS Growth

EPS Growth	2024	2025
High	30.2%	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.